ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	20/169	134/7206	2.64757287434e-11
ko04064	NF-kappa B signaling pathway	13/169	96/7206	3.04653544251e-07
ko04060	Cytokine-cytokine receptor interaction	18/169	191/7206	4.35650787136e-07
ko04621	NOD-like receptor signaling pathway	15/169	157/7206	3.54148936518e-06
ko04668	TNF signaling pathway	13/169	120/7206	4.05544093447e-06
ko05150	Staphylococcus aureus infection	7/169	36/7206	1.62098640511e-05
ko05168	Herpes simplex infection	15/169	182/7206	2.15183343727e-05
ko04660	T cell receptor signaling pathway	12/169	124/7206	3.05744609868e-05
ko05164	Influenza A	14/169	167/7206	3.38391545824e-05
ko04662	B cell receptor signaling pathway	10/169	88/7206	3.59347083521e-05
ko04658	Th1 and Th2 cell differentiation	10/169	96/7206	7.64178102877e-05
ko05162	Measles	11/169	120/7206	0.000108374992997
ko04611	Platelet activation	13/169	163/7206	0.00010874327962
ko04666	Fc gamma R-mediated phagocytosis	11/169	122/7206	0.000125829375055
ko05167	Kaposi's sarcoma-associated herpesvirus infection	14/169	191/7206	0.000146181218653
ko05161	Hepatitis B	13/169	173/7206	0.000198108565265
ko04630	Jak-STAT signaling pathway	11/169	132/7206	0.000253514445449
ko05140	Leishmaniasis	8/169	75/7206	0.000343493548376
ko04610	Complement and coagulation cascades	8/169	79/7206	0.000490614584102
ko05340	Primary immunodeficiency	5/169	30/7206	0.000592339914604
ko04659	Th17 cell differentiation	9/169	106/7206	0.000811200280665
ko05160	Hepatitis C	11/169	153/7206	0.000893764190785
ko04217	Necroptosis	12/169	178/7206	0.000928386642934
ko04210	Apoptosis	12/169	180/7206	0.0010238708986
ko04672	Intestinal immune network for IgA production	5/169	37/7206	0.00158723678991
ko04650	Natural killer cell mediated cytotoxicity	8/169	97/7206	0.00190275205084
ko04664	Fc epsilon RI signaling pathway	7/169	77/7206	0.00208560901231
ko04623	Cytosolic DNA-sensing pathway	5/169	41/7206	0.00253057493268
ko04622	RIG-I-like receptor signaling pathway	6/169	62/7206	0.0031586478864
ko04657	IL-17 signaling pathway	7/169	87/7206	0.00416925298774
ko05133	Pertussis	7/169	87/7206	0.00416925298774
ko05152	Tuberculosis	11/169	187/7206	0.00438663391376
ko04145	Phagosome	10/169	162/7206	0.0046503942041
ko05323	Rheumatoid arthritis	7/169	89/7206	0.00472838882459
ko04620	Toll-like receptor signaling pathway	7/169	100/7206	0.00887053851273
ko04612	Antigen processing and presentation	6/169	77/7206	0.0091393741954
ko05166	HTLV-I infection	14/169	292/7206	0.00933415540135
ko05145	Toxoplasmosis	8/169	126/7206	0.00934060876093
ko05321	Inflammatory bowel disease (IBD)	5/169	56/7206	0.00973583662237
ko04921	Oxytocin signaling pathway	11/169	209/7206	0.00990162152449
ko05131	Shigellosis	6/169	82/7206	0.0122699796598
ko04917	Prolactin signaling pathway	6/169	87/7206	0.0160888219688
ko05330	Allograft rejection	3/169	24/7206	0.0178632924601
ko04010	MAPK signaling pathway	14/169	321/7206	0.0220312370895
ko04670	Leukocyte transendothelial migration	8/169	151/7206	0.0253275413347
ko05132	Salmonella infection	6/169	98/7206	0.0272238251915
ko05320	Autoimmune thyroid disease	3/169	29/7206	0.0296238735989
ko05169	Epstein-Barr virus infection	10/169	206/7206	0.0297737041099
ko05416	Viral myocarditis	4/169	55/7206	0.0394618186107
ko04144	Endocytosis	14/169	342/7206	0.0409662144069